Lily Dara, MD

Dr. Dara is an NIH funded physician-scientist specialized in the care of patients with gastrointestinal and liver disorders. She is a leader in the field of drug induced liver injury and hepatotoxicity and has authored numerous articles and book chapters on the mechanisms of liver injury and hepatocyte cell death due to drug and toxic compounds. In addition, Dr. Dara studies autoimmune hepatitis, and primary biliary cholangitis (PBC), two chronic immune-mediated liver diseases that disproportionately affect women.

In her clinical practice she performs routine gastrointestinal procedures such as endoscopy and colonoscopy. She treats various forms of liver disease such as cirrhosis of the liver and its complications, autoimmune liver disorders such as primary biliary cholangitis (PBC), primary sclerosing cholangitis (PSC), and autoimmune hepatitis, viral hepatitis, alcohol-associated liver disease, metabolic and fatty liver disease among other liver and GI diseases.